skip to Main Content
There is a rapidly expanding, virtually unregulated competitor to medical cannabis in Maryland. It’s called Delta-8.

You no longer need a medical card to legally get high on cannabis in Maryland.

The state spent years setting up a medical cannabis industry that is tightly regulated at every step from seed to sale. Dispensaries, processors and cultivators spent millions of dollars creating an entirely new industry under the impression that everyone would compete under the same rules.

It’s called Delta-8.

Delta-8 is one of more than a hundred closely related compounds found in the cannabis plant called cannabinoids. Its chemical structure is nearly identical to THC, the main psychoactive component in cannabis.

Delta-8 is found in small amounts in hemp. It’s legal thanks to a loophole in federal legislation that passed in 2018. And it’s virtually unregulated. As a result, it’s generally cheaper than the cannabis sold at dispensaries. And it’s rapidly grown into an industry that some estimate has $50 million of annual revenue in Maryland — if not more.

Critics and users alike are concerned that it could pose a public health risk. More than 20 states have regulated or banned the sale of Delta-8, including Virginia, starting July 1. [Read More @ The Baltimore Sun]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…

Tech glitch on 4/20 caused Missouri cannabis businesses to lose sales

April 20 is a day recognized globally for celebrating cannabis culture, but it’s also like the cannabis industry’s Black Friday. Dispensaries offer deals designed to inspire people to flood their stores…

Japan’s cannabis market growing rapidly amid regulatory shift

Japan’s cannabis market expanded sixfold over four years to ¥24 billion ($154 million) in 2023, a trend that is expected to accelerate with the amendment in December of cannabis laws,…

Ispire Leads with a Focus on Safety and Innovation

Los Angeles-based Ispire Technologies (NASDAQ: ISPR) is a three-year-old company built on the foundation (and reputation) of a global enterprise with many years of experience as an ODM (original design…

More Categories

Back To Top
×Close search
Search